First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC

NCT04363255 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: Etoposide Injection
DRUG: Carboplatin Injection
DRUG: Cisplatin injection
DRUG: Toripalimab
DRUG: Anlotinib hydrochloride

Sponsor

Taizhou Hospital